Showing results (71-80 of 206) with videos related to

Sort By:
Pageof 21
Pharmacoeconomics|July 8, 2022
Belimumab for Treating Active Autoantibody-Positive Systemic Lupus Erythematosus: An Evidence Review Group Perspective of a NICE Single Technology AppraisalThomas Otten, Rob Riemsma, Ben Wijnen, et al.
Nephrology, Dialysis, Transplantation : Official Publication of the European Dialysis and Transplant Association - European Renal Association|April 30, 2015
Lupus nephritis management guidelines comparedSuzanne Wilhelmus, Ingeborg M Bajema, George K Bertsias, et al.
Arthritis and Rheumatism|May 29, 2007
Tumor necrosis factor alpha activates release of B lymphocyte stimulator by neutrophils infiltrating the rheumatoid jointLakhvir K Assi, See Heng Wong, Andreas Ludwig, et al.
Arthritis Care & Research|August 5, 2015
Incidence of End-Stage Renal Disease Among Newly Diagnosed Systemic Lupus Erythematosus Patients: The Georgia Lupus RegistryLaura Plantinga, S Sam Lim, Rachel Patzer, et al.
BMJ Open|July 23, 2013
Belimumab: a technological advance for systemic lupus erythematosus patients? Report of a systematic review and meta-analysisNgianga-Bakwin Kandala, Martin Connock, Amy Grove, et al.
BMJ Open|December 19, 2019
Belimumab after B cell depletion therapy in patients with systemic lupus erythematosus (BEAT Lupus) protocol: a prospective multicentre, double-blind, randomised, placebo-controlled, 52-week phase II clinical trialAlexis Jones, Patrick Muller, Caroline J Dore, et al.
Rheumatology International|October 26, 2020
'But you don't look sick': a qualitative analysis of the LUPUS UK online forumMelanie Sloan, Michael Bosley, Moira Blane, et al.
Rheumatology Advances in Practice|February 19, 2021
The impact of the COVID-19 pandemic on the medical care and health-care behaviour of patients with lupus and other systemic autoimmune diseases: a mixed methods longitudinal studyMelanie Sloan, Caroline Gordon, Rupert Harwood, et al.
Arthritis and Rheumatism|January 31, 2002
Candidate T cell epitopes of the human La/SSB autoantigenMarie L Davies, Emma J Taylor, Caroline Gordon, et al.
Rheumatology (Oxford, England)|November 26, 2013
Epratuzumab for patients with moderate to severe flaring SLE: health-related quality of life outcomes and corticosteroid use in the randomized controlled ALLEVIATE trials and extension study SL0006Vibeke Strand, Michelle Petri, Kenneth Kalunian, et al.
Pageof 21